Published in Vaccine Weekly, February 22nd, 2006
This latest member of the Qscan family is the first subscription offering of the vaccine adverse-event reporting system. Qscan-VAERS is released with the Version 3.2 multiple-database version of the core Qscan system. It will allow users' comparisons of VAERS data with the post market vaccine adverse event data as reported in the freedom of information adverse event reporting system data of the U.S. Food & Drug Administration (FDA). Current subscribers to Qscan-FDA will have a 30-day pilot period to experience both the VAERS database benefits and multiple...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.